Article

Comparative effectiveness of natalizumab and fingolimod and injectable therapies in patients with pediatric multiple sclerosis: A registry-based retrospective cohort study

2022-10-13

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background and Objectives</h4> Patients with pediatric-onset multiple sclerosis (POMS) typically experience higher levels of inflammation with more frequent relapses and reach irreversible disability at a younger age than adult-onset patients. There have been few randomized placebo-controlled clinical trials of multiple sclerosis (MS) disease-modifying therapies (DMTs) in patients with POMS,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9584f804-5eaf-59b5-bca7-f404b8661dc0
DOI: 10.1101/2022.10.12.22280969

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Comparative effectiveness of natalizumab and fingolimod and injectable therapies in patients with pediatric multiple sclerosis: A registry-based retrospective cohort studyDOI 10.1101/2022.10.12.22280969Read

Effect of Early Treatment Intensity on Progression Independent of Relapse Activity and Disability Accumulation in Multiple SclerosisSemantic proximity Read

[Multiple sclerosis in childhood and adolescence : Complex, chronic and differentiated].Semantic proximity Read

Complications of Therapeutic Plasma Exchange in Pediatric Neuroimmune DisordersSemantic proximity Read

The role of age in choosing high-efficacy treatment for multiple sclerosis – an Austrian MS Database studySemantic proximity Read

Ocrelizumab versus Natalizumab in Relapsing-Remitting Multiple Sclerosis: A Registry-Linked Electronic Health Records StudySemantic proximity Read

Efficacy and safety of mycophenolate mofetil for steroid reduction in neuromyelitis optica spectrum disorder: a prospective cohort studySemantic proximity Read

Validating therapy decisions by reasons for therapy switch in relapsing-remitting multiple sclerosisSemantic proximity Read

Pediatric multiple sclerosis.Semantic proximity Read

Disease Modifying Therapies and COVID-19 Severity in Multiple SclerosisSemantic proximity Read

Associations of DMT Therapies with COVID-19 Severity in Multiple Sclerosis: An International Cohort StudySemantic proximity Read

Real-world Safety and Efficacy of Dimethyl Fumarate in Relapse-Remitting Multiple Sclerosis Patients: A Regional Cohort Report of the Iranian PatientsSemantic proximity Read

Age-Specific Differences in Omalizumab-Related Adverse Drug Reaction Signals between Children and Adults: An Analysis Based on the FAERS DatabaseSemantic proximity Read